FOXO1 and hepatocellular carcinoma: Additionally, the FOXM1/RB1/DNMT3B transcriptional regulatory complex can suppress the expression of FOXO1, resulting in decreased levels of FOXO1 target p16, p21, and p27 in hepatocellular carcinoma (HCC) [45].